Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up.
about
Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer.Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients.Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
P2860
Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Breast carcinoma with an Oncot ...... eries with clinical follow-up.
@en
Breast carcinoma with an Oncot ...... eries with clinical follow-up.
@nl
type
label
Breast carcinoma with an Oncot ...... eries with clinical follow-up.
@en
Breast carcinoma with an Oncot ...... eries with clinical follow-up.
@nl
prefLabel
Breast carcinoma with an Oncot ...... eries with clinical follow-up.
@en
Breast carcinoma with an Oncot ...... eries with clinical follow-up.
@nl
P2093
P2860
P356
P1433
P1476
Breast carcinoma with an Oncot ...... eries with clinical follow-up.
@en
P2093
Clifford A Hudis
Fresia Pareja
Hannah Y Wen
Maura N Dickler
Melissa Krystel-Whittemore
Sujata Patil
Zenica L Bowser
P2860
P304
P356
10.1002/CNCR.30271
P407
P577
2016-08-15T00:00:00Z